News
Videos
Conferences
Events
Resources
Subscribe

|Articles|April 22, 2015

Dr. Primo Lara Discusses Emerging Therapies in Kidney Cancer

Primo Neary Lara Jr., associate director of Translational Research at the UC Davis Comprehensive Cancer Center, discusses emerging therapies for patients with kidney cancer.

Primo Neary Lara Jr., associate director of Translational Research and co-leader of the Cancer Therapeutics Program at UC Davis Comprehensive Cancer Center, discusses emerging therapies for patients with kidney cancer.

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Dr. William A. Hall sat down with CURE to discuss the impact of technologies like artificial intelligence on gastrointestinal cancer care.

Understanding the Role of Artificial Intelligence in Gastrointestinal Cancer Care

ByDr. William A. Hall

January 19th 2026

Dr. Surbhi Sidana

How Tecvayli With Darzalex Works to Treat Multiple Myeloma

ByDr. Surbhi Sidana

January 19th 2026

Image of man.

Oya Gilbert Advocates for Collaboration and Support for Patients With Myeloma

January 19th 2026

Image of two men.

Multidisciplinary Care Enhances Lung Cancer Treatment Decisions

ByDr. Graeme M. Rosenberg,Dr. Jorge J. Nieva

January 16th 2026

Joe McDonough reflects on the bonds he’s formed in the childhood cancer community and what they’ve taught him about empathy and shared experience.

Discussing Bonds and Empathy in the Childhood Cancer Community

ByJoe McDonough

January 16th 2026

Trending on CURE

Chronic Myeloid Leukemia: From Diagnosis to Ongoing Management

Given Months to Live, She’s Now a Five-Year Glioblastoma Survivor

Tecvayli With Darzalex Could Be ‘Truly Transformative’ in Multiple Myeloma

Understanding the Role of Artificial Intelligence in Gastrointestinal Cancer Care

First U.S. Patient Treated With Alveltamig for Small Cell Lung Cancer